Peter Rijnbeek

BLOG – Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study

by

Key Findings To our knowledge this is the largest COVID-19 study to date with more than twenty-four million COVID-19 patients and twenty-six databases across three continents. This study provides essential context on the complications in unvaccinated subjects and shows a striking increase in risk of outcomes after COVID-19, like pulmonary embolism (x12), disseminated intravascular coagulation … Read more

DARWIN EU Open Call for Data Partners

by

DARWIN EU®, the Data Analysis and Real World Interrogation Network, has accomplished its first year of establishment. Following the set-up of the DARWIN EU® Coordination Centre in February 2022, the first ten Data Partners were onboarded. We are proud that multiple data sources included in this first year have been mapped to the OMOP CDM … Read more

EHDEN welcomes Roche to its Consortium

by

Brussels, Belgium, 28 March 2023: EHDEN (European Health Data & Evidence Network) is delighted to announce that Roche has become a partner of the EHDEN Consortium. They now join the 11 public partners, and 13 industry partners, adding their expertise, resources, and support in creating an ecosystem for working with real-world data across Europe. The private-public … Read more

Professor Peter Rijnbeek, EHDEN Coordinator, gives his inaugural lecture accepting his full professorship, highlighting with RWD/RWE, scale matters

by

EHDEN is extremely proud of our Coordinator, Prof Peter Rijnbeek, who gave his inaugural lecture to publicly accept his appointment as a full Professor of Medical Informatics, at Erasmus MC Faculty of Erasmus University Rotterdam on March 3rd. This is a delightful tradition in The Netherlands for a new Professor to outline his/her scientific view … Read more

BLOG – Generative Pre-trained Transformers and real world research: on the band wagon with ChatGPT 3

by

Right now, we are all riding on the Gartner Hype Cycle with regards to ‘AI bots’ and generative pre-trained transformers, based on large language models, such as OpenAI’s ChatGPT 3, or Google’s Bard, based on its LaMDA technology. Despite the excitement, or even hysteria around developments in generative AI (artificial intelligence, but perhaps more EI, … Read more

EHDEN not-for-profit and Lundbeck collaborate on first research programme, in Neuroscience

by

Brussels, Belgium, 21st of February 2023:  The European Health Data and Evidence Network (EHDEN) and Lundbeck announce they have begun formative stages of neuroscience research with the EHDEN network and potential partners, including other Pharma companies. As an Innovative Medicines Initiative (IMI) project, EHDEN will reach end-of-its project phase in April 2024. To ensure EHDEN’s … Read more

EHDEN Academy Courses for Non-Experts Extended to 4th Module on Patient Reported Outcomes

by

With module 4 now posted, EHDEN (European Health Data & Evidence Network), and IMI H20 (Health Outcomes Observatory) launched their lay-language course collaboration on Patient Reported Outcomes. This is the 4th course in the series of introductory-level courses on the EHDEN Academy, which have been co-produced in partnership with the European Patients’ Forum. This introductory … Read more

EHDEN Academy used in 100 countries worldwide in all regions, training thousands to date

by

We are delighted that the EHDEN Academy has reached the remarkable milestone of course users in 100 countries, a rapid expansion since its launch as part of the IMI EHDEN project in April 2020. With almost 3,500 course enrollees since launch, this is an excellent start and foundation to the Academy and our vision of … Read more

BLOG – International collaboration – advancing the use of real-world evidence in health technology assessment

by

Dr Ravinder Claire outlines recent progress towards greater use of real-world evidence in regulatory decision-making. He also considers the implications and opportunities for NICE and our stakeholders. This blog entry was previously published by NICE on 24th January 2023 (here).   Real-world evidence has the potential to transform current models of evidence generation. It allows … Read more